Bio Insight Bio Feature
Good Enough and Cheap, or Prove It's Equivalent? Asia's Biosimilar Trust Gap
There is a number that captures Asia's biosimilar paradox in a single line. According to Samsung Bioepis's quarterly tracking of the United States market, ...
June 12, 2026 | Analysis
AI Must Shift Healthcare From Crisis Response To Early Intervention Across APAC
As healthcare systems across Asia Pacific confront mounting workforce shortages, ageing populations, and rising chronic disease burdens, artificial intelli...
June 10, 2026 | News
The Footnote Test: When the Sustainability Pledge Met the Earnings Call
The slide had been on the screen for almost a minute, and no one in the room would meet its eye. It was a simple chart, the kind that the company's invest...
June 04, 2026 | Analysis
Innovation Powerhouse or Inflated Bubble? Reading China’s First-in-Class Boom
A decade ago, the phrase “Chinese first-in-class drug” would have drawn a raised eyebrow in any Western boardroom. China made generics, copied ...
June 02, 2026 | Analysis | By arcilla.fran@biopharmaapac.com
When America Builds a Wall: Who Inherits China’s Displaced Biotech Work?
When President Trump signed the FY2026 National Defense Authorization Act on December 18, 2025, the biopharmaceutical industry finally got the law it had s...
June 02, 2026 | Analysis | By arcilla.fran@biopharmaapac.com
Engineering Precision In Chromatography From Development To Commercial Scale
Chromatography in Bioprocessing For pilot and commercial purification of monoclonal antibodies and recombinant proteins, chromatography remains the centra...
April 24, 2026 | Analysis
Can AI close the MSK inequality gap? Improving access to musculoskeletal care in the UK
Behind these statistics lies a deeper and more troubling social divide: that the greatest burden is carried by those in our most deprived communities and m...
April 14, 2026 | Opinion | By Peter Grinbergs, Chief Medical Officer and Co‑founder of EQL
From Staging to Survival: How AI-Driven Histological Analysis Is Solving Colorectal Cancer's Overtreatment Problem
The hidden cost of getting treatment decisions wrong Colorectal cancer (CRC) is one of the most prevalent and lethal cancers worldwide, ranking among the ...
April 02, 2026 | Expert Insight | By Dr. Torbjørn Furuseth, CEO and Co-Founder, DoMore Diagnostics
From Concept to Validation-Ready: How Nelipak’s Singapore Hub Aims to Accelerate APAC Healthcare Packaging to Global Scale
Nelipak Healthcare Packaging has launched a new Asia-Pacific Technical Development Center in Singapore, establishing an integrated hub that unites ...
March 17, 2026 | Interaction
2026: AI Transforms China’s Pharma Sector and Drives More Strategic M&A Deals
The preceding decade was marked by rapid growth and robust policy backing; however, the landscape has fundamentally evolved. Research and development expen...
March 13, 2026 | Opinion | By By Adam Zhang Yu, Founder & CEO, Collabrium Partners
Turning Frontline Reality Into Policy Action For Cancer Care In Asia
Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...
February 02, 2026 | Expert Insight
China Originated Innovation Is Rising. Global Expectations Are Rising Even Faster.
The momentum is real—and so is the level of scrutiny. As more programs move beyond regional boundaries, expectations from global biopharma companies ...
February 02, 2026 | News | By Anil Kane, executive director, global head of technical and scientific affairs, Thermo Fisher Scientific
From Capacity to Capability: How 2026 can be the catalyst for what APAC’s Biopharma Growth Needs Next
Beyond Scale: What Will Sustain APAC’s Biopharma Leadership Asia-Pacific’s rise in global biopharma is no longer about whether the region can ...
January 21, 2026 | News | By Joonho Choi, Vice President, Asia-Pacific, Cytiva
Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad
As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is ...
January 19, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
